GSA Capital Partners LLP purchased a new position in Proto Labs, Inc. (NYSE:PRLB – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,603 shares of the industrial products company’s stock, valued at approximately $864,000.
Other institutional investors also recently modified their holdings of the company. Illinois Municipal Retirement Fund boosted its stake in shares of Proto Labs by 2.4% during the 1st quarter. Illinois Municipal Retirement Fund now owns 12,871 shares of the industrial products company’s stock worth $734,000 after acquiring an additional 300 shares in the last quarter. Horizon Investments LLC raised its position in shares of Proto Labs by 3.4% during the fourth quarter. Horizon Investments LLC now owns 11,886 shares of the industrial products company’s stock worth $601,000 after purchasing an additional 395 shares during the period. Federated Hermes Inc. raised its position in shares of Proto Labs by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 30,748 shares of the industrial products company’s stock worth $1,556,000 after purchasing an additional 469 shares during the period. Group One Trading LLC purchased a new stake in shares of Proto Labs during the fourth quarter valued at $25,000. Finally, Creative Planning lifted its holdings in shares of Proto Labs by 9.0% during the third quarter. Creative Planning now owns 6,883 shares of the industrial products company’s stock valued at $344,000 after purchasing an additional 569 shares during the last quarter. Institutional investors own 84.54% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on PRLB. Needham & Company LLC upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective on the stock in a report on Monday, August 3rd. Weiss Ratings raised shares of Proto Labs from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, August 3rd. Wall Street Zen lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Benchmark upped their price target on shares of Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Finally, Zacks Research raised shares of Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $89.00.
Insider Buying and Selling
In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the transaction, the director owned 32,505 shares in the company, valued at $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.30% of the stock is owned by company insiders.
Proto Labs Stock Down 6.5%
PRLB stock opened at $84.93 on Wednesday. Proto Labs, Inc. has a 12-month low of $45.10 and a 12-month high of $93.00. The company has a market cap of $2.03 billion, a price-to-earnings ratio of 67.94 and a beta of 1.40. The company has a 50 day moving average of $80.37 and a two-hundred day moving average of $69.74.
Proto Labs (NYSE:PRLB – Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The business had revenue of $149.34 million for the quarter, compared to analysts’ expectations of $144.53 million. During the same period in the previous year, the company posted $0.41 EPS. Proto Labs’s revenue was up 10.5% on a year-over-year basis. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, research analysts anticipate that Proto Labs, Inc. will post 1.46 EPS for the current year.
Proto Labs Company Profile
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
See Also
- Five stocks we like better than Proto Labs
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
